Call Options Transactions Made in Q4 2023 in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX) during Q4 2023. The information is specifically focused on institutions that hold call options of EAGLE PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
87.5KNew |
$405K - $1.33M
|
87.5K
$52.5K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
3.6K+ 257.14% |
$16.7K - $54.8K
|
5K
$3K
|